Transpact Enter. — 360° view

Transpact Enter, a company in the Medical Equipment & Supplies industry, reported revenue of ₹0.09 crore and net profit of ₹0.04 crore for the March 2026 quarter.

Transpact Enter. (BSE: TRANSPACT) closed at ₹90.70 on 20 Nov 2026, down 45.0% over the past year. Its market capitalisation is ₹4 crore and it trades at 43.9 times earnings.

Share price
₹90.70 (20 Nov 2026)
Market cap
₹4 Cr (20 Nov 2026)
P/E
43.87 (20 Nov 2026)
Revenue
₹0 Cr (March 2026 quarter)
Net profit
₹0 Cr (March 2026 quarter)
ROCE
13.9% (FY26)
ROE
16.2% (FY26)
Book value
₹14.0 (FY26)
Dividend yield
0.00% (FY26)
52-week high / low
₹234.90 / ₹81.47 (20 Nov 2026)
1-year return
-45.0% (to 20 Nov 2026)
Sector
Healthcare
Industry
Medical Equipment & Supplies
Symbol
BSE: TRANSPACT

Incorporated in 2013, Transpact Enterprises Ltd deals in investment portfolio, Investment advisory, Corporate funding, Market consulting, for various clients

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.